Diagnamed Holdings Corp.
DMED
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.30M | 969.60K | 967.50K | 983.30K | 671.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.23M | 915.50K | 983.10K | 1.01M | 762.30K |
| Operating Income | -1.23M | -915.50K | -983.10K | -1.01M | -762.30K |
| Income Before Tax | -1.32M | -901.30K | -974.80K | -1.01M | -813.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.32 | -0.90 | -0.97 | -1.01 | -0.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.32M | -901.30K | -974.80K | -1.01M | -813.70K |
| EBIT | -1.23M | -915.50K | -983.10K | -1.01M | -762.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 451.89M | 435.90M | 403.71M | 370.00M | 342.54M |
| Average Diluted Shares Outstanding | 451.89M | 435.90M | 403.71M | 370.00M | 342.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |